ENFERMEDADES REUMÁTICAS
Hospital Virgen de la Arrixaca
Murcia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Virgen de la Arrixaca (24)
2024
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study
Reumatologia Clinica, Vol. 19, Núm. 6, pp. 312-318
2022
2021
-
Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
Rheumatology (Oxford, England), Vol. 60, Núm. 11, pp. 5329-5336
2020
-
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662
-
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)
Lupus, Vol. 29, Núm. 1, pp. 27-36
-
Hormonal Dependence and Cancer in Systemic Lupus Erythematosus
Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224
-
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: Data from the RELESSER Registry
Rheumatology (United Kingdom), Vol. 59, Núm. 8, pp. 2043-2051
2019
-
Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature
Reumatologia Clinica, Vol. 15, Núm. 1, pp. 34-42
-
Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 6, pp. 1025-1029
2018
-
Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients
Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 1, pp. 22-27
-
Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project
Reumatologia Clinica, Vol. 14, Núm. 2, pp. 90-96
-
Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern (Rheumatology International, (2018), 38, 9, (1735-1740), 10.1007/s00296-018-4097-y)
Rheumatology International
-
The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern
Rheumatology International, Vol. 38, Núm. 9, pp. 1735-1740
2017
-
Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study
Rheumatology International, Vol. 37, Núm. 7, pp. 1195-1202
-
Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus
Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 1, pp. 38-45
-
Juvenile- and adult-onset systemic lupus erythematosus: A comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
Clinical and Experimental Rheumatology, Vol. 35, Núm. 6, pp. 1047-1055
-
Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: A multicentre, non-interventional study
Clinical and Experimental Rheumatology, Vol. 35, Núm. 3, pp. 423-430